RenovoRx Operating Income from 2010 to 2024
| RNXT Stock | USD 1.25 0.03 2.34% |
Operating Income | First Reported 2010-12-31 | Previous Quarter -11.4 M | Current Value -10.8 M | Quarterly Volatility 2.8 M |
Check RenovoRx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among RenovoRx's main balance sheet or income statement drivers, such as Net Interest Income of 116.5 K, Interest Income of 64.3 K or Depreciation And Amortization of 5.1 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. RenovoRx financial statements analysis is a perfect complement when working with RenovoRx Valuation or Volatility modules.
RenovoRx | Operating Income |
Latest RenovoRx's Operating Income Growth Pattern
Below is the plot of the Operating Income of RenovoRx over the last few years. Operating Income is the amount of profit realized from RenovoRx operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of RenovoRx is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. RenovoRx's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in RenovoRx's overall financial position and show how it may be relating to other accounts over time.
| Operating Income | 10 Years Trend |
|
Operating Income |
| Timeline |
RenovoRx Operating Income Regression Statistics
| Arithmetic Mean | (5,333,813) | |
| Coefficient Of Variation | (53.39) | |
| Mean Deviation | 2,201,060 | |
| Median | (3,896,000) | |
| Standard Deviation | 2,847,912 | |
| Sample Variance | 8.1T | |
| Range | 8.2M | |
| R-Value | (0.72) | |
| Mean Square Error | 4.2T | |
| R-Squared | 0.52 | |
| Significance | 0 | |
| Slope | (460,019) | |
| Total Sum of Squares | 113.5T |
RenovoRx Operating Income History
About RenovoRx Financial Statements
RenovoRx shareholders use historical fundamental indicators, such as Operating Income, to determine how well the company is positioned to perform in the future. Although RenovoRx investors may analyze each financial statement separately, they are all interrelated. The changes in RenovoRx's assets and liabilities, for example, are also reflected in the revenues and expenses on on RenovoRx's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Operating Income | -11.4 M | -10.8 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for RenovoRx Stock Analysis
When running RenovoRx's price analysis, check to measure RenovoRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RenovoRx is operating at the current time. Most of RenovoRx's value examination focuses on studying past and present price action to predict the probability of RenovoRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RenovoRx's price. Additionally, you may evaluate how the addition of RenovoRx to your portfolios can decrease your overall portfolio volatility.